Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimal trEatment for coroNary Drug Eluting Stent In-Stent Restenosis: Paclitaxel Versus Sirolimus Coated Balloons Versus Everolimus Eluting Stents - The OPEN ISR Study

NCT04862052 is registered in ClinicalTrials.gov with Semmelweis University Heart and Vascular Center as lead sponsor.

NCT NCT04862052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04862052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimal trEatment for coroNary Drug Eluting Stent In-Stent Restenosis: Paclitaxel Versus Sirolimus Coated Balloons Versus Everolimus Eluting Stents - The OPEN ISR Study
Lead sponsor
Semmelweis University Heart and Vascular Center
Phase
Not applicable
Overall status
Completed
Start date
April 26, 2021
Completion date
January 30, 2025
Enrollment
108 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stent restenosis